ScreenerHero

FMSFresenius Medical Care AG & Co. KGaA

NYSE · US · Healthcare · Medical Care Facilities · freseniusmedicalcare.com
23.43USDMkt Cap: 12.47B $P/E: 12.20

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and di…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$95.21BUSDP/E 14.4
FRE
Fresenius SE & Co. KGaA
$28.53BUSDP/E 16.8
THC
Tenet Healthcare Corporation
$22.61BUSDP/E 10.9
FME
Fresenius Medical Care AG & Co. KGaA
$11.72BUSDP/E 12.1
EHC
Encompass Health Corporation
$11.87BUSDP/E 20.1
DVA
DaVita Inc.
$11.16BUSDP/E 14.7
ENSG
The Ensign Group, Inc.
$10.46BUSDP/E 28.1
UHS
Universal Health Services, Inc. Class B
$10.45BUSDP/E 7.2
CHE
Chemed Corporation
$7.07BUSDP/E 27.2
PACS
PACS Group Inc.
$7.00BUSDP/E 25.9
LFST
LifeStance Health Group Inc. Common Stock
$4.76BUSDP/E 95.9
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.46BUSDP/E 22.6
MCOV-B
Medicover AB (publ)
$3.50BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.66BUSDP/E 26.2
OPCH
Option Care Health, Inc.
$3.55BUSDP/E 18.0
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.3
BKD
Brookdale Senior Living Inc.
$2.82BUSD
EMEIS
Emeis SA
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.59BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.40BUSDP/E 36.5

Key Statistics

Company
Market Cap12.47B $
Enterprise Value23.36B $
Revenue (TTM)19.43B $
Gross Profit5.03B $
Net Income (TTM)978.37M $
Revenue/Share34.64 USD
Last Price23.43 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees107.2K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)12.20
P/E (Forward)6.38
PEG0.82
EV/EBITDA8.58
EV/Revenue1.20
P/S0.64
P/B0.86
EPS (TTM)1.94
EPS (Forward)3.67
52W Range
23.3829% of range23.57
52W High23.57 USD
52W Low23.38 USD
Profitability
Gross Margin25.62%
Oper. Margin10.77%
EBITDA Margin14.01%
Profit Margin4.98%
ROE7.35%
ROA3.16%
Growth
Revenue Growth1.40%
Earnings Growth5.50%
Cash Flow & Leverage
Operating CF2.68B $
CapEx (TTM)915.37M $
FCF Margin10.41%
FCF Yield16.22%
Net Debt9.92B $
Net Debt/EBITDA3.64
Balance Sheet
Debt/Equity0.81
Current Ratio1.07
Quick Ratio0.63
Book Value/Sh27.29 USD
Cash/Share1.994 USD
Dividends
Fwd Div Rate0.8700 USD
Trail. Div Rate1.490 USD
Div. Yield3.72%
5Y Avg Yield1.30%
Payout Ratio45.03%
Ex-Div DateMay 22, 2026
Pay DateJun 8, 2026
Splits
Last Split2:1
Split DateDec 4, 2012
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)26.03 USD
Upside (mean)+11.1%
Target Range17.54 USD – 38.60 USD
$17.54+11.1% to mean$38.60
# Analysts7
Ownership
Shares Out.532.22M
Float363.78M
Insiders0.00%
Institutions9.92%
Short Interest
Short Ratio4.4d
Short % Out.0.50%
Shares Short2.68M
Short (prev mo.)2.92M
Technical
SMA 5023.92 (-2.0%)
SMA 20023.16 (+1.2%)
Beta0.84
S&P 52W Chg19.18%
Avg Vol (30d)791.56K
Avg Vol (10d)665.94K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—